Frequency of genetic polymorphism of calcium channels gene CACNA1C in healthy individuals and patients with arterial hypertension

Cover Page

Abstract

Aim. To determine the frequency of polymorphism of calcium channels gene CACNA1C (rs1006737) in healthy individuals and patients with hypertension.

Methods. 94 patients with arterial hypertension and 102 healthy residents were examined. The age ranged from 18 to 35 years. Detection of SNP calcium channel genes CACNA1C (rs1006737) was performed by real time PCR. Checking of sampling genotypes’ for being in Hardy-Weinberg equilibrium and χ2-test were performed, and hazards ratio (OR) was evaluated as well.

Results. It was established that allele G of CACNA1C gene (rs1006737) was 1,3 times less frequent in patients with hypertension compared to control group, and its frequency was 0.58 vs. 0.76, respectively (χ2=14.42, р=0.0001). In patients with hypertension allele A was detected 1.75 times more often with the frequency 0.42, and in healthy individuals the frequency was 0.24 (χ2=14.42, р=0.0001). Use of general inheritance model demonstrated that G/G genotype was 1.5 times less frequent and A/A genotype was 3.2 times more frequent in patients with hypertension than in healthy individuals (χ2=12.75, р=0.002). The risk of hypertension development was higher in carriers of allele A (HR=2.3, 95% CI 1.49-3.53, p=0.0001) and genotype A/A (HR=3.9, 95% CI 1.49-9.68, p=0.002) of SNP gene of CACNA1C molecule (rs1006737).

Conclusion. Allele A and genotype A/A SNP CACNA1C (rs1006737) are predisposing factors to the development of arterial hypertension, carriership of G allele and genotype G/G CACNA1C (rs1006737) reduces the risk of hypertension development.

About the authors

B S Pushkarev

Chita State Medical Academy

Author for correspondence.
Email: pushkarevboris@rambler.ru
Chita, Russia

O V Bol’shakova

Chita State Medical Academy

Email: pushkarevboris@rambler.ru
Chita, Russia

T V Sibiryakova

Zabaikalie Regional Bureau of Forensic Medical Expertise

Email: pushkarevboris@rambler.ru
Chita, Russia

A S Emel’yanov

Chita State Medical Academy

Email: pushkarevboris@rambler.ru
Chita, Russia

A A Gerasimov

City clinical hospital №1

Email: pushkarevboris@rambler.ru
Chita, Russia

Yu A Vitkovskiy

Chita State Medical Academy

Email: pushkarevboris@rambler.ru
Chita, Russia

References

  1. Логунов Н.А., Никитин Я.О., Собанчеев Е.В. и др. Влияние полиморфизма гена эндотелиальной синтазы оксида азота на толщину слоя нервных волокон сетчатки при различных схемах гипотензивной терапии у больных глаукомой. Мед. генетика. 2014; 13 (1): 27-31.
  2. Сахарова Д.А., Марковский А.В., Витковский Ю.А. Генетический полиморфизм C-159T гена рецептора CD14 у больных хроническим вирусным гепатитом C. Забайкальский мед. вестн. 2015; (3): 61-66.
  3. Györke S., Terentyev D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovascular. Res. 2008; 77 (2): 245-255. doi: 10.1093/cvr/cvm038.
  4. Laitinen P.J., Brown K.M., Piippo K. et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation. 2001; 103 (4): 485-490.
  5. Ling T.Y., Wang X.L., Chai Q. et al. Regulation of cardiac CACNB2 by microRNA-499: Potential role in atrial fibrillation. BBA Clin. 2017; 7: 78-84. doi: 10.1016/j.bbacli.2017.02.002.
  6. Пушкарёв Б.С., Витковский Ю.А. Кальциевые ионные каналы. Часть II. Забайкальский мед. вестн. 2016; (1): 93-104.
  7. Mannhardt I., Breckwoldt K., Letuffe-Brenière D. et al. Human engineered heart tissue: Analysis of contractile force. Stem. Cell Reports. 2016; 7 (1): 29-42. doi: 10.1016/j.stemcr.2016.04.011.
  8. Дымшиц Г.М., Саблина О.В. «Разорванные» гены и сплайсинг. Вавиловский ж. генетики и селекции. 2014; 18 (1): 71-80.

Statistics

Views

Abstract: 383

PDF (Russian): 290

Dimensions

Article Metrics

Metrics Loading ...

PlumX


© 2017 Pushkarev B.S., Bol’shakova O.V., Sibiryakova T.V., Emel’yanov A.S., Gerasimov A.A., Vitkovskiy Y.A.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies